Company news

CStone Pharmaceuticals news in 2024

CStone Pharmaceuticals's news releases, calls and decks from 2024, newest first.

View company

CStone Announces Submission of Clinical Trial Application in Australia for CS2009, an Innovative PD-1/VEGF/CTLA-4 Trispecific Antibody

December 23, 2024

CStone Pharmaceuticals Announces MHRA Approval of Sugemalimab for First-Line Treatment of Non-Small Cell Lung Cancer in the UK

November 1, 2024

Decks in 2024